Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer-Reference-Cited by-同舟云学术

Development and Clinical Validation of an In Situ Biopsy-Based Multimarker Assay for Risk Stratification in Prostate Cancer

Published:2015-03-02 Issue:11 Volume:21 Page:2591-2600
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Blume-Jensen Peter,Berman David M.,Rimm David L.,Shipitsin Michail,Putzi Mathew,Nifong Thomas P.,Small Clayton,Choudhury Sibgat,Capela Teresa,Coupal Louis,Ernst Christina,Hurley Aeron,Kaprelyants Alex,Chang Hua,Giladi Eldar,Nardone Julie,Dunyak James,Loda Massimo,Klein Eric A.,Magi-Galluzzi Cristina,Latour Mathieu,Epstein Jonathan I.,Kantoff Philip,Saad Fred

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 152 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genomics in active surveillance and post-prostatectomy patients: A review of when and how to use effectively;Current Urology Reports;2024-06-13

2. Analysis of the Gene Networks and Pathways Correlated with Tissue Differentiation in Prostate Cancer;International Journal of Molecular Sciences;2024-03-24

3. Tissue-Based Genomic Testing in Prostate Cancer: 10-Year Analysis of National Trends on the Use of Prolaris, Decipher, ProMark, and Oncotype DX;Clinics and Practice;2024-03-19

4. The Impact of Positron Emission Tomography Imaging and Tumor Molecular Profiling on Risk Stratification, Treatment Choice, and Oncological Outcomes of Patients with Primary or Relapsed Prostate Cancer: An International Collaborative Review of the Existing Literature;European Urology Oncology;2024-02

5. How to Integrate Prostate Cancer Biomarkers in Urology Clinical Practice: An Update;Cancers;2024-01-11